| Budget Amount *help |
¥9,880,000 (Direct Cost: ¥7,600,000、Indirect Cost: ¥2,280,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Outline of Final Research Achievements |
This research has a motivation on how to create new medical technology and how to disseminate it. Therefore, this research focuses on medical drugs according to an axis from creation of innovative medical technology to access to them. This research's main purposes;(1) to measure consistently value of medical innovation from multiple views. (2)to show how we should set drug price to give pharmaceutical firms R&D incentives and patient's cost burden, (3)to show what health insurance system to deal consistently value of medical innovation.
|
